← Back to Search

Mesh

SSLS Procedure for Pelvic Organ Prolapse (COMET Trial)

N/A
Recruiting
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years postoperatively
Awards & highlights

COMET Trial Summary

This trial is to compare two different types of vaginal surgery for correcting pelvic organ prolapse in women. One type uses mesh and the other doesn't, and they want to see which is better.

Eligible Conditions
  • Pelvic Organ Prolapse

COMET Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years postoperatively
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years postoperatively for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Composite outcome of 3 objective signs and 1 subjective symptom of POP (yes/no answers). The definition of surgical success, used in the OPTIMAL trial as described in the description below.
Secondary outcome measures
Change in maximal POP of vaginal compartments via POPQ, obtained by research personnel (nurse or clinical fellow) trained in POPQ and blinded to group allocation. POP will be quantified and compared to baseline.
Change in questionnaire scores between the 2 groups from baseline to 12 and 24 months: Pelvic organ prolapse/ Incontinence Sexual Questionnaire, IUGA-Revised (PISQ-IR)
Change in questionnaire scores between the 2 groups from baseline to 6 weeks, 12 and 24 months postoperatively: Pelvic Floor Distress Inventory (PFDI-20)
+9 more
Other outcome measures
Health economic evaluation

COMET Trial Design

2Treatment groups
Active Control
Group I: SSLS ProcedureActive Control1 Intervention
Group II: BSSVF-M ProcedureActive Control1 Intervention

Find a Location

Logistics

Travel, including flights, are covered

Your expenses for travel tickets for this trial will be reimbursed.

Who is running the clinical trial?

University of British ColumbiaLead Sponsor
1,413 Previous Clinical Trials
2,466,603 Total Patients Enrolled
1 Trials studying Pelvic Organ Prolapse
100 Patients Enrolled for Pelvic Organ Prolapse
Centre for Health Evaluation and Outcome SciencesUNKNOWN
1 Previous Clinical Trials
576 Total Patients Enrolled
University of AlbertaOTHER
886 Previous Clinical Trials
384,420 Total Patients Enrolled

Media Library

BSSVF-M Procedure (Mesh) Clinical Trial Eligibility Overview. Trial Name: NCT02965313 — N/A
Pelvic Organ Prolapse Research Study Groups: SSLS Procedure, BSSVF-M Procedure
Pelvic Organ Prolapse Clinical Trial 2023: BSSVF-M Procedure Highlights & Side Effects. Trial Name: NCT02965313 — N/A
BSSVF-M Procedure (Mesh) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02965313 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment for this clinical research study still open to participants?

"According to the clinicaltrials.gov listing, this clinical study is actively seeking participants; it was initially posted on November 1st 2016 and last revised on May 17th 2022."

Answered by AI

How many participants is the upper limit to join this research experiment?

"Affirmative. Clinicaltrials.gov's records suggest that this experiment is still recruiting patients, having been first posted on November 1st 2016 and most recently revised on May 17th 2022. A total of 358 participants are required from a single site for the trial to be completed successfully."

Answered by AI
~43 spots leftby Apr 2025